79 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
, customer, supplier, principal, shareholder, investor, collaborator, strategic partner, licensee, contact or prospect of the Company (or of its partners
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
16 Jan 24
InMed Pharmaceuticals Provides Business Update and Milestones for 2024
2:12pm
significant, but we believe the results are clinically important based on additional analyses.
BayMedica – Ingredients supplier to the health … and is an ingredients supplier to brands within the health and wellness industry. BayMedica demonstrated significant year-over-year revenue growth throughout 2023
8-K
EX-99.1
INM
InMed Pharmaceuticals Inc
14 Nov 23
InMed Reports First Quarter Fiscal 2024 Financial Results and Provides Business Update
4:36pm
available to patients. Our commercial subsidiary, BayMedica, continues to make steady progress as a B2B supplier of rare cannabinoids to the Health … in Itch, the official journal of the International Forum for the Study of Itch (IFSI).
BayMedica Commercial Subsidiary
BayMedica, a leading supplier
424B3
9i4qh8zye
13 Nov 23
Prospectus supplement
5:05pm
8-K
EX-99.1
38ladce
29 Sep 23
InMed Pharmaceuticals Reports Full Year Fiscal 2023 Financial Results and Provides Business Update
5:18pm
8-K
EX-99.1
tjlg y1zk
24 Jul 23
Regulation FD Disclosure
4:26pm
8-K
ltw1vs59ou2710xzmzl
24 Jul 23
Regulation FD Disclosure
4:26pm
8-K
EX-99.1
ylh3vb8 tvrj5k5pq
20 Jul 23
Regulation FD Disclosure
2:18pm
8-K
5kc6qxcpb9zmy07gl
20 Jul 23
Regulation FD Disclosure
2:18pm
8-K
EX-99.1
4whau genuqw
16 May 23
InMed Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update
1:47pm
424B3
b56uefalesvumxxh
15 Dec 22
Prospectus supplement
11:42am